Table 2.
Hepatocellular Carcinoma Tumor Characteristics
| TACE + | TACE − | Significance | |
|---|---|---|---|
| Population | 6432 (17.00%) | 31400 (83.00%) | |
| Intrahepatic Disease | 5219 (81.14%) | 18849 (60.03%) | <0.0001 |
| Unifocal | 2554 (48.94%) | 8646 (45.87%) | |
| Multifocal | 2146 (41.12%) | 7966 (42.26%) | |
| Unspecified | 519 (9.94%) | 2237 (11.87%) | |
| Extrahepatic Disease | 367 (5.71%) | 3272 (10.42%) | |
| Unspecified | 846 (13.15%) | 9279 (29.55%) | |
| Vascular Invasion | <0.0001 | ||
| YES | 1019 (15.84%) | 3572 (11.38%) | |
| NO | 3814 (59.30%) | 13301 (42.36%) | |
| UNKNOWN | 1599 (24.86%) | 14527 (46.26%) | |
| Tumor Size | < 0.0001 | ||
| Mean Size (cm) | 5.8 (3.8) | 6.4 (4.4) | <0.0001 |
| Median Size (cm) | 5.0 | 5.3 | <0.0001 |
| <2cm | 360 (5.60%) | 1401 (4.46%) | |
| 2–5cm | 2412 (37.52%) | 7320 (23.32%) | |
| >5cm | 2307 (35.88%) | 9082 (28.93%) | |
| UNKNOWN | 1350 (21.00%) | 13593 (43.30%) | |
| AJCC | < 0.0001 | ||
| I | 1488 (23.15%) | 4325 (13.78%) | |
| II | 914 (14.22%) | 2038 (6.49%) | |
| III | 789 (12.27%) | 2574 (8.20%) | |
| IV | 207 (3.22%) | 2510 (7.99%) | |
| UNKNOWN | 3031 (47.15%) | 19949 (63.54%) |
TACE Transarterial Chemoembolization; cm Centimeter; AJCC American Joint Committee on Cancer